Building Biopharma Resilience In Developing Gene Therapies

Leszek Lisowski, an Associate Professor at the University of Sydney and Children’s Medical Research Institute, plays a crucial role in advancing the development of gene therapies aimed at treating rare and serious diseases. Here, he shares his perspectives on how government entities and the biopharmaceutical industry can support his groundbreaking work.
Learn about the opportunities and challenges surrounding gene therapies, the importance of collaboration between biopharma startups and academia to bring better therapies to patients, difficulties with the talent pipeline, and more.